EMERGENCY:New or repeated seizures of any kind in a child or young adult — including sudden brief jerks of one limb or the whole body that throw them forward; sudden loss of consciousness during or after a jerk; severe drowsiness, difficulty waking, irregular breathing, or choking; inability to swallow, repeated chest infections, or severe weight loss; sudden onset of stiffening, fits, or worsening behaviour in a child with a known SSPE diagnosis. SSPE seizures are often resistant to one drug and need urgent expert review — don't manage them alone. —call040-46324365immediately — 24 hours, 7 days— 24/7
Subacute Sclerosing Panencephalitis (SSPE) — Specialist Care in Hyderabad at KIMS
Subacute Sclerosing Panencephalitis — SSPE — is a rare but devastating brain disease that appears years after a measles infection, usually in childhood or adolescence. The measles virus, instead of being completely cleared, stays hidden in the brain in a changed form. After 5–10 years (sometimes longer) it begins to slowly damage brain cells, causing a gradual loss of memory, learning, movement, and consciousness. SSPE is one of the strongest reminders of why measles vaccination matters — every child fully vaccinated is a child protected from SSPE.
SSPE is a progressive, almost invariably fatal, slowly progressive encephalitis caused by persistent measles virus in the brain, appearing months to years (typically 5–10 years) after the initial measles infection. The measles virus, after causing the initial infection, establishes a latent persistent infection in neurons and glial cells, gradually spreading to produce progressive inflammatory encephalitis. SSPE presents in childhood or adolescence (average age of onset 11 years). The 4-stage Jabbour classification: Stage I — personality change, intellectual decline, school failure; Stage II — myoclonic jerks (the hallmark, periodic, stereotyped, every 5–10 seconds) + seizures; Stage III — rapid deterioration, dementia, spasticity, blindness; Stage IV — vegetative state. EEG hallmark: periodic complexes — high-amplitude stereotyped bursts every 5–10 seconds, synchronised with the clinical myoclonic jerks. CSF: massively elevated measles IgG (CSF measles antibody index diagnostic) with low-normal total protein. No curative treatment; isoprinosine (inosiplex) and intrathecal interferon may slow progression. Prevention: MMR vaccination. India has the largest global SSPE burden due to incomplete MMR coverage and measles before age 2 years (which carries the highest SSPE risk).
- Prognosis — almost invariably fatal, with exceptions
- SSPE is a progressive, almost invariably fatal disorder, typically leading to death within 1–3 years, although prolonged survival and rare remissions can occur. Care therefore combines disease-modifying attempts with palliative support from diagnosis onward.
- Measles at 2 years — the highest SSPE risk
- The risk of SSPE after measles is highest when measles occurs before age 2 years — the immature immune system fails to fully clear the measles virus from the nervous system, the blood-brain barrier is more permeable, and the immature brain allows viral persistence. The measles-to-SSPE interval is typically 5–10 years (1 to 20+). India's high SSPE burden reflects the large pool of children who had measles before age 2 before comprehensive MMR coverage.
- 4-stage Jabbour classification — recognising the stages
- STAGE I: Subtle personality change, intellectual decline, school failure — often missed or mistaken for depression. STAGE II: Diagnostic hallmark — periodic, stereotyped, whole-body or segmental myoclonic jerks every 5–10 seconds; seizures; EEG periodic complexes appear; CSF measles IgG elevated. STAGE III: Rapid deterioration, dementia, spasticity, optic atrophy + pigmentary retinopathy. STAGE IV: Vegetative state, decorticate/decerebrate posturing, death (usually pneumonia).
- Periodic EEG complexes — the electrophysiological signature
- High-amplitude, stereotyped, generalised bursts (2–3 seconds duration, 1–3 Hz rhythm within the burst) recurring at regular intervals of 5–10 seconds, corresponding precisely to the clinical myoclonic jerks. Between bursts, the EEG background may be relatively suppressed. This burst-suppression pattern in a school-age or adolescent child is diagnostic of SSPE in the appropriate clinical context.
- CSF measles IgG — the diagnostic test
- Massively elevated CSF measles IgG with low-normal total protein and normal or near-normal cell count. The CSF measles antibody index (CSF measles IgG to serum measles IgG ratio, corrected for blood-brain barrier) is markedly elevated (>1.5), indicating intrathecal antibody production. Serum measles IgG is also very high. The CSF-serum measles antibody ratio is diagnostic.
- India's SSPE burden — the prevention tragedy
- India has the largest burden of SSPE in the world: incomplete MMR vaccination coverage; a large pool of children who had natural measles before routine vaccination; and the specific high-risk factor of measles in infancy. SSPE is largely preventable — one dose of measles vaccine reduces SSPE risk by >99%. Countries that have eliminated measles have eliminated SSPE. Every SSPE case is a preventable tragedy.
- Management — supportive care and slowing progression
- No treatment reverses or cures SSPE. Isoprinosine (inosiplex) 50–100 mg/kg/day orally may slow Stage II–III progression. Intrathecal interferon alpha via Ommaya reservoir may slow progression in some studies. Antiseizure medications for seizures and myoclonus (valproate, levetiracetam, clonazepam). Supportive care: aspiration pneumonia prevention, skin care, nutritional support (gastrostomy when swallowing is unsafe), pain management, family psychological support.
- Family support and palliative care at KIMS
- Honest, compassionate, ongoing communication about diagnosis, prognosis, and trajectory. Multidisciplinary team meetings. Early introduction of palliative care principles alongside disease-modifying attempts. Community nurse visits, respite care, psychological support. Advance care planning — when to consider limiting interventions — discussed proactively, not as a crisis decision. Social work and palliative care involved from diagnosis.
| Fact | Details |
|---|---|
| Prognosis | SSPE is a progressive, almost invariably fatal disorder, typically leading to death within 1–3 years, although prolonged survival and rare remissions can occur. |
| Cause | Persistent measles virus in neurons · 5–10 year latency after measles infection · Measles before age 2 = highest risk · India has the largest global SSPE burden |
| 4-stage Jabbour | I: personality change + school failure · II: periodic myoclonic jerks (every 5–10 sec) + seizures · III: rapid deterioration + dementia + blindness · IV: vegetative state |
| EEG hallmark | Periodic high-amplitude stereotyped bursts every 5–10 seconds · Synchronised with clinical myoclonic jerks · Diagnostic in Stage II–III |
| CSF diagnostic test | Elevated measles IgG in CSF · CSF measles antibody index >1.5 · Low-normal total protein · Normal cells · Confirms intrathecal antibody production |
| Management | No cure · Isoprinosine (inosiplex) 50–100 mg/kg/day may slow progression · Intrathecal interferon alpha · Seizure control · Supportive care · Palliative care from diagnosis |
| Prevention | MMR vaccination · One dose >99% reduction in SSPE risk · Countries with measles elimination have eliminated SSPE · Every SSPE case is a preventable tragedy |
| Contact | 040-44885000 (SSPE specialist clinic, paediatric neurology) · Multidisciplinary SSPE care + family support + palliative care at KIMS |
About This Condition
SSPE at a Glance
What is it?
A slowly progressive brain disease caused by a persistent measles virus, appearing years after the original measles infection.
When does measles cause it?
Most children with SSPE had measles before age 2, often before vaccination was given. The lag to SSPE is usually 6–10 years.
How common in India?
Among the highest in the world — estimated at 21 per million measles cases, much higher in unvaccinated communities.
Typical age
Children 5–15 years, but can appear in early adulthood.
First symptoms
Falling grades in school, behaviour change, clumsiness, hand-writing deterioration.
Hallmark
Sudden jerks every 5–10 seconds (periodic myoclonus) — often the clinching clue.
Diagnosis
Clinical picture + EEG (specific periodic pattern) + raised anti-measles antibody levels in blood and CSF.
Treatment
No cure. Anti-seizure medicines + isoprinosine + interferon (intrathecal or systemic) may slow progression. Supportive care is the cornerstone.
Diagnosis at KIMS
A Devastating Late Measles Complication — Diagnosed, Managed, and Supported at KIMS
Subacute Sclerosing Panencephalitis — SSPE — is a rare but devastating brain disease that appears years after a measles infection, usually in childhood or adolescence. The measles virus, instead of being completely cleared, stays hidden in the brain in a changed form. After 5–10 years (sometimes longer) it begins to slowly damage brain cells, causing a gradual loss of memory, learning, movement, and consciousness. SSPE is one of the strongest reminders of why measles vaccination matters — every child fully vaccinated is a child protected from SSPE.
There is no cure for SSPE today. But early diagnosis, the right anti-seizure and immunomodulatory treatment, supportive nursing, and family support can extend useful life, reduce suffering, and in some patients slow the disease meaningfully. At KIMS Neuroscience we run a structured SSPE service alongside our paediatric neurology and palliative-care teams.
Book an SSPE Consultation
Speak directly with the KIMS paediatric neurology and palliative-care teams — same-day EEG and MRI, anti-measles antibody testing through accredited laboratories, combination disease-modifying therapy offered to selected patients, structured palliative-care liaison, and home-care planning. Outpatient paediatric neurology clinics run Monday to Saturday. Bring: any school reports showing recent decline, video recordings of any unusual movements, vaccination card, previous MRI and EEG, blood reports.
040-44885000Neuro Emergency: 040-46324365 (24×7)Why SSPE Happens
Measles is usually a short infection — fever, rash, cough, red eyes — that the immune system clears in a couple of weeks. But in a small number of children, especially those infected very young (under 2 years), the virus enters the brain and stays there in a changed, slowed-down form. The brain's immune defences cannot fully reach the virus, and over years it slowly multiplies inside brain cells, damaging them and triggering low-grade chronic inflammation.
Eventually, after 5–10 years (sometimes shorter, sometimes much longer), the damage reaches a tipping point and symptoms appear. Once they appear, they get worse over months — not years. The exact reason why some children get SSPE and most do not is unclear; immune system differences, the age at which measles was caught, and the strain of virus all seem to matter.
THE SINGLE MOST IMPORTANT FACT ABOUT SSPE
SSPE is almost entirely preventable. A child who has received two doses of measles vaccine, on time, has an extremely low risk of measles — and therefore an extremely low risk of SSPE.
In India, where measles outbreaks still happen in pockets of unvaccinated or partially vaccinated children, SSPE has not disappeared.
Every parent of a child diagnosed with SSPE has the right to two clear truths: this is not your fault — and the future is now about making your child as comfortable and dignified as possible.
Why SSPE Happens — and How the Disease Moves
SSPE arises when measles virus persists in the brain after the original infection and slowly multiplies over years before symptoms appear. It is almost entirely preventable by full measles vaccination — and the natural history once symptoms begin is measured in months to years.
Stage 1 — Behaviour and intellect
Often the first noticeable change is at school — grades drop, attention falters, the child becomes forgetful, hand-writing worsens. Mood changes: irritability, withdrawal, sometimes mild psychiatric symptoms. Mild clumsiness, occasional unexplained falls. This stage may last weeks to months and is often missed or attributed to stress or laziness.
Stage 2 — Myoclonic jerks and seizures
Sudden brief jerks of the trunk, arms, or whole body — every 5 to 10 seconds, sometimes throwing the child forward. Classic seizures may also appear. Speech becomes slurred and slowed. Walking becomes unsteady; loss of fine motor skills. This is the stage at which most children come to medical attention.
Stage 3 — Severe movement and consciousness changes
Stiff, rigid posture (decerebrate or decorticate). Loss of speech, severe swallowing difficulty. Persistent involuntary movements. Bedridden; needs full care for feeding, hygiene, and breathing.
Stage 4 — End-stage
Coma, irregular breathing, autonomic instability (changing blood pressure and temperature). Death is usually from chest infection, autonomic failure, or aspiration.
How the disease moves
The classic SSPE course is steadily downhill over 1 to 3 years. About 10% of patients have a slower, more drawn-out course over 5–10 years. A small number (around 5%) have natural pauses or temporary improvement — but the overall trend is downward. Very rarely, the disease appears to stabilise for long periods. We watch for these patients because they may benefit most from immunomodulatory treatment.
How We Diagnose SSPE at KIMS
SSPE is diagnosed at KIMS through a structured seven-stage workflow that begins with a careful history of the trigger measles infection and very first symptoms, proceeds to a developmental and neurological examination, then to EEG (the periodic complex is highly characteristic), MRI, anti-measles antibody testing in blood and CSF (the confirmatory test), a formal retinal eye examination, and a careful workup to rule out other slowly progressive brain diseases :
Detailed history
When did the symptoms start? What were the very first changes — school, behaviour, hand-writing, walking? Has there been a definite history of measles in childhood, especially before age 2? Vaccination history — every dose, with dates.
Neurological and developmental examination
Cognitive screening — appropriate for the child's age. Observation for myoclonic jerks and other movement abnormalities. Vision check — chorioretinitis (a specific eye change) is often present and can be the earliest clue. Full neurological examination with regular re-mapping to track progression.
EEG
The classic SSPE EEG shows a specific 'periodic complex' pattern — bursts of high-voltage waves repeating every 4–10 seconds, often coinciding with the myoclonic jerks. This pattern is highly characteristic and often clinches the diagnosis.
MRI of the brain
Early in the disease, MRI may look surprisingly normal. Later, it shows progressive shrinkage and inflammation in specific areas — periventricular white matter, basal ganglia, brainstem. We repeat MRIs to track progression and rule out other causes.
Antibody testing — the confirmatory test
Raised anti-measles IgG antibody levels in both blood and CSF (cerebrospinal fluid) — with the CSF level disproportionately high. This pattern is highly specific to SSPE. Done with reliable laboratory partners; results within days.
Eye examination
A formal retinal examination is essential — chorioretinitis (specific inflammation at the back of the eye) is found in many SSPE patients and can support the diagnosis.
Ruling out other causes
Other slowly progressive brain diseases — leukodystrophies, autoimmune encephalitis, certain metabolic conditions — can mimic SSPE early. Targeted blood and genetic tests narrow the diagnosis.
Treatment
Treatment — What Helps
The aims of treatment
There is no cure today — but the aims are clear: slow the disease where possible; control symptoms — especially seizures and myoclonus; maintain comfort and dignity; support the family through a long and difficult course.
Disease-modifying medicines (modest effect)
Isoprinosine (inosine pranobex): taken by mouth long term. Several studies suggest some patients live longer or stabilise temporarily. Generally well tolerated. Interferon-alpha: given either as injections under the skin or directly into the spinal fluid through a reservoir (intrathecal). The intrathecal route reaches the brain better but is invasive. Combination therapy (isoprinosine + interferon) is used in many Indian centres including KIMS for selected patients in early stages. Realistic expectations: these medicines may slow progression in a subset of patients but do not reverse the disease. Decisions are made carefully with the family.
Anti-seizure and anti-myoclonus medicines
Valproate, levetiracetam, clonazepam, and others — used in combination to control the jerks and seizures. Myoclonic jerks in SSPE are often the most distressing symptom for the child and family. Good control transforms quality of life even when the disease is progressing.
Supportive care — the cornerstone
Nutrition: dietitian-led feeding plan. As swallowing worsens, a feeding tube (nasogastric or gastrostomy) is offered to prevent malnutrition and aspiration. Chest care: regular position changes, suction, chest physiotherapy to prevent pneumonia. Skin care: pressure-area prevention, regular position changes, soft mattresses. Bladder and bowel care: routine toileting, treatment of constipation, urinary catheter only when essential. Pain and comfort: regular review for hidden pain (mouth ulcers, bony pain, joint contractures). Spasticity management: physiotherapy, splinting, botulinum toxin for focal spasticity, oral muscle relaxants.
Family support
SSPE is one of the most emotionally demanding diagnoses a family can face. Counselling, financial planning, and respite care are part of standard support. We connect families with paediatric palliative-care teams and SSPE-specific support groups. Siblings need attention too — they often carry hidden grief and fear.
Living with SSPE — Practical Guidance
Day-to-day care of a child with SSPE evolves with the disease — from gentle school attendance and making precious memories in the early stages, through home-based nursing and family training in the middle, to recognising red flags and having difficult but compassionate conversations about end-of-life choices :
School and social life — early stage
In stage 1 and early stage 2, gentle school attendance helps the child feel normal and connected. Teachers should know the diagnosis and adjust expectations. Photographs, videos, and special outings while the child can still enjoy them — these become precious for families.
Home care setup — as the disease progresses
A hospital bed at home, suction equipment, nebuliser, oxygen, and a pulse oximeter. Training for at least two family members or carers in basic nursing — feeding, suction, position change, seizure first aid. Regular home visits by a nurse or palliative-care team if available locally.
Recognising red flags
New seizure pattern, rapid worsening of consciousness, fever and cough, refusal to feed, vomiting, or weight loss — all need urgent medical contact.
Difficult conversations — when and how
Discussions about resuscitation, ventilation, and end-of-life choices should happen early and revisit regularly, not just in a crisis. These conversations are part of compassionate care, not giving up. Families who have had these talks are more peaceful at the end.
Prevention — Vaccination Is Everything
SSPE is almost entirely preventable by full measles vaccination. Two doses of measles vaccine — on time, with catch-up where doses were missed — protect not only the individual child but the entire community, including infants too young to be vaccinated.
Two doses of measles vaccine prevent SSPE
All children should receive measles vaccine on time — at 9 months and 15 months in the Indian schedule (combined as MR or MMR in many states).
Catch-up vaccination
If a child has missed doses, catch-up vaccination at any age is recommended.
Adult vaccination
Adults born after 1960 who never had measles or two documented vaccine doses should also be vaccinated.
Community protection
Vaccination protects not only the individual child but the whole community — including babies under 9 months who cannot yet be vaccinated. If you are unsure of your child's vaccination status, please bring the vaccination card or come in for a review. Catch-up is straightforward.
KIMS — SSPE Service Highlights
Paediatric neurology consultant cover
Senior, multidisciplinary.
EEG and MRI
Same-day, 1.5T and 3T.
Anti-measles antibody testing
Through accredited laboratories.
Combination disease-modifying therapy
Offered to selected patients.
Palliative-care liaison
Yes, structured.
Home-care planning
Family training and equipment guidance.
Seizure and myoclonus management
Multi-drug, individualised.
24×7 emergency cover
040-46324365.
Related Conditions
SSPE belongs to the family of neuro-infection complications evaluated and managed at KIMS Neuroscience. Explore related conditions
FAQs
Frequently Asked Questions
A child whose school grades have begun to drop. Sudden brief jerks every few seconds. A history of measles years ago, often before age two. SSPE is rare but devastating — and even though there is no cure today, early diagnosis, expert seizure care, supportive nursing, and family support transform what is possible.
At KIMS Neuroscience, Secunderabad, Hyderabad, the SSPE service is run by senior, multidisciplinary paediatric neurology with same-day EEG and MRI (1.5T and 3T), anti-measles antibody testing through accredited laboratories, combination disease-modifying therapy offered to selected patients, structured palliative-care liaison, family training and home-care planning, and individualised multi-drug seizure and myoclonus management. Open emergency line: 040-46324365 (24×7). Outpatient paediatric neurology clinics run Monday to Saturday. Appointments: 040-44885000. Email: neuroscience@kimshospitals.com. Bring: any school reports showing recent decline, video recordings of any unusual movements, vaccination card, previous MRI and EEG, blood reports.
International enquiries: info@kimsneurosciences.com